Bullfrog AI Holdings (BFRG) Stock Overview
Through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
BFRG Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Bullfrog AI Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.76 |
| 52 Week High | US$4.84 |
| 52 Week Low | US$0.65 |
| Beta | 0.68 |
| 1 Month Change | -25.59% |
| 3 Month Change | -48.37% |
| 1 Year Change | -64.03% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -84.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| BFRG | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -8.6% | -7.2% | 0.3% |
| 1Y | -64.0% | -11.2% | 16.2% |
Return vs Industry: BFRG underperformed the US Healthcare Services industry which returned -11% over the past year.
Return vs Market: BFRG underperformed the US Market which returned 16.9% over the past year.
Price Volatility
| BFRG volatility | |
|---|---|
| BFRG Average Weekly Movement | 12.0% |
| Healthcare Services Industry Average Movement | 8.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BFRG's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BFRG's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Vin Singh | www.bullfrogai.com |
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases; and Modified HSV-1, which is in the discovery phase, for the treatment of modified colorectal cancer.
Bullfrog AI Holdings, Inc. Fundamentals Summary
| BFRG fundamental statistics | |
|---|---|
| Market cap | US$7.80m |
| Earnings (TTM) | -US$6.76m |
| Revenue (TTM) | US$116.67k |
Is BFRG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BFRG income statement (TTM) | |
|---|---|
| Revenue | US$116.67k |
| Cost of Revenue | US$94.78k |
| Gross Profit | US$21.89k |
| Other Expenses | US$6.78m |
| Earnings | -US$6.76m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.59 |
| Gross Margin | 18.76% |
| Net Profit Margin | -5,794.85% |
| Debt/Equity Ratio | 2.9% |
How did BFRG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/15 06:17 |
| End of Day Share Price | 2026/01/15 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bullfrog AI Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.